OMEGA THERAPEUTICS INC (OMGA) Stock Analyst Ratings
USA - NASDAQ:OMGA - US68217N1054 - Common Stock
0.1426 USD
-0.02 (-10.82%)
0.11 USD
-0.03 (-22.86%)
ChartMill assigns a Buy % Consensus number of 83% to OMGA. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 13.26. This target is 9198.74% above the current price.
OMGA was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about OMGA.
In the previous month the buy percentage consensus was at a similar level.
OMGA was analyzed by 7 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-11-15 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2024-08-15 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-08-07 | Chardan Capital | Maintains | Buy -> Buy |
| 2024-08-07 | Wedbush | Reiterate | Outperform -> Outperform |
| 2024-06-18 | Raymond James | Initiate | Outperform |
| 2024-05-13 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-07 | Chardan Capital | Maintains | Buy -> Buy |
| 2024-04-30 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-04-03 | Piper Sandler | Reiterate | Overweight -> Overweight |
| 2024-04-01 | Chardan Capital | Maintains | Buy -> Buy |
| 2024-01-04 | Wedbush | Reiterate | Outperform -> Outperform |
| 2023-11-13 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-11-10 | Wedbush | Maintains | Outperform -> Outperform |
| 2023-09-01 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-08-04 | Chardan Capital | Reiterate | Buy -> Buy |
| 2023-06-06 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-05-08 | Chardan Capital | Reiterate | Buy |
| 2023-03-31 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-03-24 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-03-10 | JonesTrading | Initiate | Buy |
| 2023-03-03 | Piper Sandler | Maintains | Overweight |
| 2022-12-08 | HC Wainwright & Co. | Initiate | Buy |
| 2022-09-23 | Chardan Capital | Initiate | Buy |
| 2022-05-24 | Goldman Sachs | Maintains | Neutral |
| 2022-05-23 | Piper Sandler | Maintains | Overweight |
| 2021-08-24 | Wedbush | Initiate | Outperform |
| 2021-08-24 | Goldman Sachs | Initiate | Neutral |
| 2021-08-24 | Piper Sandler | Initiate | Overweight |
| 2021-08-24 | Jefferies | Initiate | Buy |
OMEGA THERAPEUTICS INC / OMGA FAQ
What is the average price target for OMEGA THERAPEUTICS INC (OMGA) stock?
7 analysts have analysed OMGA and the average price target is 13.26 USD. This implies a price increase of 9198.74% is expected in the next year compared to the current price of 0.1426.
How do analysts rate OMEGA THERAPEUTICS INC (OMGA)?
The consensus rating for OMEGA THERAPEUTICS INC (OMGA) is 82.8571 / 100 . This indicates that analysts generally have a positive outlook on the stock.
How many analysts cover OMEGA THERAPEUTICS INC (OMGA) stock?
The number of analysts covering OMEGA THERAPEUTICS INC (OMGA) is 7.